M
Maddalena Peghin
Researcher at University of Udine
Publications - 81
Citations - 1818
Maddalena Peghin is an academic researcher from University of Udine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 57 publications receiving 887 citations. Previous affiliations of Maddalena Peghin include Autonomous University of Barcelona & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
Maddalena Peghin,Alvisa Palese,Margherita Venturini,Maria De Martino,Valentina Gerussi,Elena Graziano,Giulia Bontempo,Francesco Marrella,Alberto Tommasini,Martina Fabris,Francesco Curcio,Miriam Isola,Carlo Tascini +12 more
TL;DR: The prevalence of post-coronavirus disease 2019 (COVID-19) syndrome was 40.2% (241/599) and the presence of IgG antibodies against SARS-CoV-2 was significantly associated with the occurrence of post COVID19 syndrome (OR 2.56, 95% CI 1.48-4.38, p 0.004) as mentioned in this paper.
Journal ArticleDOI
2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections
Massimo Sartelli,Xavier Guirao,Timothy Craig Hardcastle,Yoram Kluger,Marja A. Boermeester,Kemal Rasa,Luca Ansaloni,Federico Coccolini,Philippe Montravers,Fikri M. Abu-Zidan,Michele Bartoletti,Matteo Bassetti,Offir Ben-Ishay,Walter L. Biffl,Osvaldo Chiara,Massimo Chiarugi,Raul Coimbra,Francesco Giuseppe De Rosa,Belinda De Simone,Salomone Di Saverio,Maddalena Giannella,George Gkiokas,Vladimir Khokha,Francesco M. Labricciosa,Ari Leppäniemi,Andrey Litvin,Ernest E. Moore,Ionut Negoi,Leonardo Pagani,Maddalena Peghin,Edoardo Picetti,Tadeja Pintar,Guntars Pupelis,Ines Rubio-Perez,Boris Sakakushev,Helmut Segovia-Lohse,Gabriele Sganga,Vishal G Shelat,Michael Sugrue,Antonio Tarasconi,Cristian Tranà,Jan Ulrych,Pierluigi Viale,Fausto Catena +43 more
TL;DR: A task force of experts met in Bertinoro, Italy, on June 28, 2018, for a specialist multidisciplinary consensus conference under the auspices of the World Society of Emergency Surgery (WSES) and the Surgical Infection Society Europe (SIS-E).
Journal ArticleDOI
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
Matteo Bassetti,Nadia Castaldo,Anna Maria Cattelan,Cristina Mussini,Elda Righi,Carlo Tascini,Francesco Menichetti,Claudio Maria Mastroianni,Mario Tumbarello,Paolo Grossi,S. Artioli,Novella Carannante,Ludovica Cipriani,Davide Coletto,Alessandro Russo,Margherita Digaetano,Angela Raffaella Losito,Maddalena Peghin,Alessandro Capone,Stefano Nicolè,Antonio Vena +20 more
TL;DR: This study describes the largest clinical experience using ceftolozane/tazobactam (C/T) for different Pseudomonas aeruginosa infections in Italy and demonstrates a favourable safety and tolerability profile regardless of the infection type.
Journal ArticleDOI
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
Matteo Bassetti,Matteo Bassetti,Daniele Roberto Giacobbe,Antonio Vena,Cecilia Trucchi,Filippo Ansaldi,Massimo Antonelli,Vaclava Adamkova,Cristiano Alicino,Maria-Panagiota Almyroudi,Enora Atchade,Anna Maria Azzini,Novella Carannante,Alessia Carnelutti,Silvia Corcione,Andrea Cortegiani,George Dimopoulos,Simon Dubler,Jose Luis Garcia-Garmendia,Massimo Girardis,Oliver A. Cornely,Stefano Ianniruberto,Bart Jan Kullberg,Katrien Lagrou,Clément Le Bihan,Roberto Luzzati,Manu L N G Malbrain,Maria Merelli,Ana J Marques,Ignacio Martin-Loeches,Alessio Mesini,José Artur Paiva,Maddalena Peghin,Santi Maurizio Raineri,Riina Rautemaa-Richardson,Jeroen Schouten,Pierluigi Brugnaro,Herbert D. Spapen,Polychronis Tasioudis,Jean-François Timsit,Valentino Tisa,Mario Tumbarello,Charlotte H S B van den Berg,Benoit Veber,Mario Venditti,Guillaume Voiriot,Joost Wauters,Philippe Montravers +47 more
TL;DR: The cumulative incidence of IC in 23 European ICUs was 7.07 episodes per 1000 ICU admissions, with important between-center variability, with the ultimate aim of helping to improve local infection control and antifungal stewardship projects and interventions.
Journal ArticleDOI
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study
Mario Tumbarello,Mario Tumbarello,Francesca Raffaelli,Maddalena Giannella,Elisabetta Mantengoli,Alessandra Mularoni,Mario Venditti,Francesco Giuseppe De Rosa,Loredana Sarmati,Matteo Bassetti,Gaetano Brindicci,Marianna Rossi,Roberto Luzzati,Paolo Grossi,Alberto Corona,Alessandro Capone,Marco Falcone,Cristina Mussini,Enrico Maria Trecarichi,Antonio Cascio,Elena Guffanti,Alessandro Russo,Gennaro De Pascale,Carlo Tascini,Ivan Gentile,Angela Raffaella Losito,Linda Bussini,Giampaolo Corti,Giancarlo Ceccarelli,Silvia Corcione,Silvia Corcione,Mirko Compagno,Daniele Roberto Giacobbe,Annalisa Saracino,Massimo Fantoni,Spinello Antinori,Maddalena Peghin,Paolo Bonfanti,Alessandra Oliva,Andrea De Gasperi,Giusy Tiseo,Cristina Rovelli,Marianna Meschiari,Nour Shbaklo,Teresa Spanu,Roberto Cauda,Pierluigi Viale +46 more
TL;DR: In this article, the authors retrospectively analyzed observational data on use and outcomes of CAZ-AVI therapy for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) strains.